Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM1A | O60341 | 5/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 4/20 | 0.39 |
| ▸ | MAOB | P27338 | 4/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4089888 | 1.00 | ALDH1A1 (0.46) | ALDH1A1KDM1APTGS2MAOAMAOB | |
| SCHEMBL28887354 | 1.00 | ALDH1A1 (0.46) | ALDH1A1KDM1APTGS2MAOAMAOB | |
| SCHEMBL4329150 | 0.78 | KDM1A (0.47) | KDM1AMAOAMAOBCHRM2CHRM4 | |
| SCHEMBL11424700 | 0.78 | MAOA (0.44) | KDM1AMAOAMAOBCHRM2CHRM4 | |
| SCHEMBL10515985 | 0.74 | CHRNA7 (0.44) | ALDH1A1KDM1APTGS2MAOAMAOB | |
| SCHEMBL5955814 | 0.73 | KDM1A (0.43) | ALDH1A1KDM1AMAOAMAOBCHRM2 | |
| SCHEMBL17660056 | 0.73 | KDM1A (0.43) | ALDH1A1KDM1AMAOAMAOBCHRM2 | |
| SCHEMBL3972334 | 0.73 | KDM1A (0.43) | ALDH1A1KDM1AMAOAMAOBCHRM2 | |
| SCHEMBL8993540 | 0.71 | PTGS2 (0.45) | ALDH1A1KDM1APTGS2MAOAMAOB | |
| SCHEMBL11003541 | 0.71 | PTGS2 (0.45) | ALDH1A1KDM1APTGS2MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| WO-2004111092-A1 | MODIFIED ALGINIC ACID OR ALGINIC ACID DERIVATIVES AND THERMOSETTING ANTI-REFLECTIVE COMPOSITIONS THEREOF | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2004-12-23 | — | — | WO | claimed |
| US-20040253532-A1 | Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof | MERCK PATENT GMBH (DE) | 2004-12-16 | — | — | US | claimed |
| CN-111004225-A | Novel piperazine compound and preparation method and application thereof | 兰州大学 | 2020-04-14 | — | — | CN | disclosed |
| US-9192926-B2 | Method for enhancing heterogeneous asymmetric selectivity and catalytic activity | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2015-11-24 | — | — | US | disclosed |
| US-20120322647-A1 | METHOD FOR ENHANCING HETEROGENEOUS ASYMMETRIC SELECTIVITY AND CATALYTIC ACTIVITY | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2012-12-20 | — | — | US | disclosed |
| US-7714167-B2 | Catalytic asymmetric epoxidation | UNIVERSITY OF CHICAGO (US) | 2010-05-11 | — | — | US | disclosed |
| US-7714167-B2 | Catalytic asymmetric epoxidation | UNIVERSITY OF CHICAGO (US) | 2010-05-11 | — | — | US | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| EP-1706205-B1 | A CATALYTICAL ASYMMETRIC EPOXIDATION | UNIV CHICAGO (US) | 2008-10-29 | — | — | EP | disclosed |
| US-20070203347-A1 | Catalytic asymmetric epoxidation | THE UNIVERSITY OF CHICAGO (US) | 2007-08-30 | — | — | US | disclosed |
| EP-0605677-B1 | SILICON OR SILICA SUBSTRATE WITH A MODIFIED SURFACE AND PROCESS FOR PRODUCING THE SAME | OWENS CORNING FIBERGLASS CORP (US) | 1998-06-17 | — | — | EP | disclosed |
| EP-0454463-B1 | Process for producing epoxyalcohols of high optical purity | ARCO CHEM TECH (US) | 1997-08-13 | — | — | EP | disclosed |
| EP-0422897-B1 | Recovery of water-insoluble epoxy alcohols | ARCO CHEM TECH (US) | 1994-06-22 | — | — | EP | disclosed |
| WO-1994002425-A2 | SILICON OR SILICA SUBSTRATE WITH A MODIFIED SURFACE, PROCESS FOR PRODUCING THE SAME, NEW ORTHOESTERS AND PROCESS FOR PRODUCING THE SAME | GURIT-ESSEX AG (CH) | 1994-02-03 | — | — | WO | disclosed |
| US-5278070-A | Process for producing epoxyalcohols of high optical purity | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1994-01-11 | — | — | US | disclosed |
| EP-0454463-A2 | Process for producing epoxyalcohols of high optical purity | ARCO Chemical Technology, L.P. (US) | 1991-10-30 | — | — | EP | disclosed |
| EP-0422897-A2 | Recovery of water-insoluble epoxy alcohols | ARCO Chemical Technology, L.P. (US) | 1991-04-17 | — | — | EP | disclosed |
| US-4935101-A | Process for the recovery of a water-insoluble epoxy alcohol | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1990-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203347-A1 | Catalytic asymmetric epoxidation | DUOX1, DUOX2, EPHX2 | ALDH1A1 320/4885KDM1A 1824/4885PTGS2 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.